Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
James Hardie Industries
JHX
$17.6B
| $202K | ﹤0.01% |
+16,879
| New | +$308K |
|
3352
Marvell Technology
MRVL
$216B
| $202K | ﹤0.01% |
8,906
-216,355
| -96% | -$5.19M |
|
|
CHNGU
3353
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $202K | ﹤0.01% |
+4,836
| New | +$256K |
|
3354
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
| $200K | ﹤0.01% |
762
-3,444
| -82% | -$1.17M |
|
3355
NCR Voyix
VYX
$1.12B
| $199K | ﹤0.01% |
18,336
-279,579
| -94% | -$4.8M |
|
3356
Meridian
MRBK
$233M
| $198K | ﹤0.01% |
+28,960
| New | +$267K |
|
3357
OraSure Technologies
OSUR
$261M
| $197K | ﹤0.01% |
+18,308
| New | +$131K |
|
3358
Children's Place
PLCE
$59.8M
| $196K | ﹤0.01% |
10,007
-209,733
| -95% | -$11.1M |
|
3359
Valhi
VHI
$509M
| $196K | ﹤0.01% |
15,867
+2,472
| +18% | +$42.9K |
|
3360
Waterstone Financial
WSBF
$378M
| $196K | ﹤0.01% |
13,447
-77,100
| -85% | -$1.31M |
|
|
AT
3361
DELISTED
Atlantic Power Corporation
AT
| $196K | ﹤0.01% |
91,525
+34,550
| +61% | +$78.6K |
|
|
FSD
3362
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
| $195K | ﹤0.01% |
+16,025
| New | +$234K |
|
3363
Intellicheck
IDN
$58M
| $192K | ﹤0.01% |
+56,741
| New | +$429K |
|
3364
ClearPoint Neuro
CLPT
$517M
| $191K | ﹤0.01% |
53,361
-18,112
| -25% | -$89K |
|
3365
Investar Holding Corp
ISTR
$417M
| $191K | ﹤0.01% |
14,987
-8,043
| -35% | -$163K |
|
3366
CALL
Synchrony
SYF
$26.3B
| $191K | ﹤0.01% |
+11,900
| New | +$347K |
|
|
ONCT
3367
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $191K | ﹤0.01% |
3,264
-144
| -4% | -$10.7K |
|
3368
Corbus Pharmaceuticals
CRBP
$219M
| $190K | ﹤0.01% |
+1,207
| New | +$204K |
|
3369
Boot Barn
BOOT
$4.84B
| $189K | ﹤0.01% |
14,589
+7,475
| +105% | +$238K |
|
|
ATCX
3370
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $189K | ﹤0.01% |
21,989
-585,625
| -96% | -$5.4M |
|
|
PBBI
3371
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $189K | ﹤0.01% |
+12,675
| New | +$190K |
|
3372
Biomerica
BMRA
$5.47M
| $187K | ﹤0.01% |
+3,277
| New | +$100K |
|
3373
Constellium
CSTM
$3.67B
| $187K | ﹤0.01% |
35,939
-304,113
| -89% | -$3.27M |
|
|
DX
3374
Dynex Capital
DX
$3.23B
| $186K | ﹤0.01% |
17,771
-370,415
| -95% | -$6.1M |
|
3375
Ecopetrol
EC
$34.5B
| $185K | ﹤0.01% |
19,495
-538,964
| -97% | -$8.92M |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.